NCT03275441

Brief Summary

The study evaluates whether an eye test called an electroretinogram (ERG) can be shortened and still produce the same diagnostic results. The results of this study may allow test times to be reduced which will have benefits such as improved patient compliance during shorter testing and increased clinic efficiency.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
262

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 7, 2017

Completed
24 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

September 7, 2017

Status Verified

September 1, 2017

Enrollment Period

4 months

First QC Date

March 22, 2017

Last Update Submit

September 5, 2017

Conditions

Keywords

electroretinogramERGdark-adaptationophthalmologyelectrophysiologyISCEVelectroretinographyscotopic

Outcome Measures

Primary Outcomes (2)

  • Rate of classification for ERG following 10 minute dark adaptation

    The rate of classification (normal vs abnormal) for testing conducted after 10 minutes of dark adaptation.

    (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  • Rate of classification (normal vs abnormal) for ERG following 20 minute dark adaptation

    The rate of classification (normal vs abnormal) for testing conducted after 20 minutes of dark adaptation.

    (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

Secondary Outcomes (6)

  • Response amplitude after 10 minutes

    (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  • Response amplitude after 20 minutes

    (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

  • Response timing

    (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  • Response timing

    (During first & only study visit) Dark-adapted ERG test following 20 minutes of dark adaptation

  • Response variability

    (During first & only study visit) Dark-adapted ERG test following 10 minutes of dark adaptation

  • +1 more secondary outcomes

Study Arms (1)

Adult patients

Adult patients attending hospital for clinical visual electrophysiology.

Diagnostic Test: Electroretinography

Interventions

ElectroretinographyDIAGNOSTIC_TEST

An additional electroretinogram performed after 10 minutes of dark adaptation.

Adult patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient population attending hospital for routine clinical electroretinography.

You may qualify if:

  • Patients referred to the adult visual electrophysiology service regardless of clinical condition, and who require dark-adapted electroretinography as part of their appointment
  • Male or female
  • All ethnicities

You may not qualify if:

  • Patients less than 18 years old
  • Patients who might have difficulties understanding the participant information provided (for example, those patients requiring a translator, or who have learning difficulties)
  • Patients with photosensitive epilepsy
  • Patients appointed for clinical testing urgently, or via telephone, who will not have had an opportunity to receive and review the participant information sheet ahead of the clinical appointment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Electroretinography

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Ruth Hamilton, PhD

    NHS Greater Glasgow & Clyde

    STUDY DIRECTOR
  • Kirsten Graham, MSc

    NHS Greater Glasgow & Clyde

    PRINCIPAL INVESTIGATOR
  • Richard Hagan, PhD

    NHS Royal Liverpool University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kirsten Graham, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2017

First Posted

September 7, 2017

Study Start

October 1, 2017

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

September 7, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share